ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

18F-FDG PET/CT-based deep learning radiomics predicts 5-years disease-free survival after failure to achieve pathologic complete response to neoadjuvant chemotherapy in breast cancer

Zheng, Xingxing; Huang, Yuhong; Lin, Yingyi; Zhu, Teng; Zou, Jiachen; Wang, Shuxia*; Wang, Kun*广东省人民医院; 广东医学院; 南方医科大学; 汕头大学
EJNMMI Research2023-12-6DOI: 10.1186/s13550-023-01053-7
4阅读
引用收藏
分享

摘要

Background This study aimed to assess whether a combined model incorporating radiomic and depth features extracted from PET/CT can predict disease-free survival (DFS) in patients who failed to achieve pathologic complete response (pCR) after neoadjuvant chemotherapy.Results This study retrospectively included one hundred and five non-pCR patients. After a median follow-up of 71 months, 15 and 7 patients experienced recurrence and death, respectively. The primary tumor volume underwent feature extraction, yielding a total of 3644 radiomic features and 4096 depth features. The modeling procedure employed Cox regression for feature selection and utilized Cox proportional-hazards models to make predictions on DFS. Time-dependent receiver operating characteristic (ROC) curves and the area under the ROC curve (AUC) were utilized to evaluate and compare the predictive performance of different models. 2 clinical features (RCB, cT), 4 radiomic features, and 7 depth features were significant predictors of DFS and were included to develop models. The integrated model incorporating RCB, cT, and radiomic and depth features extracted from PET/CT images exhibited the highest accuracy for predicting 5-year DFS in the training (AUC 0.943) and the validation cohort (AUC 0.938).Conclusion The integrated model combining radiomic and depth features extracted from PET/CT images can accurately predict 5-year DFS in non-pCR patients. It can help identify patients with a high risk of recurrence and strengthen adjuvant therapy to improve survival.

学科与关键词

关键词
Breast cancerDeep learningRadiomicsPET/CTNeoadjuvant chemotherapy
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
EJNMMI Research
发表日期
2023-12-06
卷期
第 13 卷, 第 1 期
页码
105
DOI
10.1186/s13550-023-01053-7
语言
ENGLISH
成果收录
SCIE
资助标注
National Natural Science Foundation of China

作者

  • Z

    Zheng, Xingxing (第一作者)

    guangdong prov peoples hosp · southern med univ

  • H

    Huang, Yuhong

    guangdong prov peoples hosp · southern med univ

查看全部 7 位作者收起作者
  • L

    Lin, Yingyi

    shantou univ

  • Z

    Zhu, Teng

    guangdong prov peoples hosp · southern med univ

  • Z

    Zou, Jiachen

    guangdong prov peoples hosp · southern med univ · guangdong med univ

  • W

    Wang, Shuxia (通讯)

    southern med univ · guangdong prov peoples hosp

  • W

    Wang, Kun (通讯)

    guangdong prov peoples hosp · southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417